| scholarly article | Q13442814 |
| P50 | author | Anthony David | Q4772364 |
| Robin Murray | Q7352679 | ||
| Carmine Pariante | Q49754517 | ||
| Flavio Dell'Acqua | Q55221709 | ||
| Antje Annechien Talea Simone Reinders | Q89744263 | ||
| Marta Diforti | Q114386386 | ||
| Stefania Bonaccorso | Q114386388 | ||
| Rowena Handley | Q114406787 | ||
| Chris Chaddock | Q114452880 | ||
| Shitij Kapur | Q20713543 | ||
| Valeria Mondelli | Q42683658 | ||
| Paola Dazzan | Q46730140 | ||
| Tiago Reis Marques | Q47504367 | ||
| P2093 | author name string | Heather Taylor | |
| Andrew Simmons | |||
| P2860 | cites work | ??? | Q94348002 |
| Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: a DTI-tractography study | Q48090782 | ||
| White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment | Q48148097 | ||
| Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging | Q48286017 | ||
| Virtual in vivo interactive dissection of white matter fasciculi in the human brain. | Q48426204 | ||
| White matter fractional anisotropy and outcome in schizophrenia | Q48467864 | ||
| Functional magnetic resonance imaging correlates of memory encoding in relation to achieving remission in first-episode schizophrenia | Q48644139 | ||
| A diffusion tensor imaging tractography atlas for virtual in vivo dissections | Q49095479 | ||
| Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination. | Q50955808 | ||
| Third-generation neuroimaging in early schizophrenia: translating research evidence into clinical utility. | Q50959572 | ||
| Prefrontal lobe dysfunction predicts treatment response in medication-naive first-episode schizophrenia. | Q51012543 | ||
| Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. | Q51972946 | ||
| Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice. | Q53396782 | ||
| Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics | Q55969829 | ||
| Disordered functional connectivity in schizophrenia1 | Q60242723 | ||
| Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia | Q80817756 | ||
| A diffusion tensor imaging study of structural dysconnectivity in never-medicated, first-episode schizophrenia | Q81468516 | ||
| Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study | Q22251379 | ||
| The positive and negative syndrome scale (PANSS) for schizophrenia | Q28301751 | ||
| Advances in functional and structural MR image analysis and implementation as FSL | Q29547164 | ||
| Fast robust automated brain extraction | Q29615078 | ||
| Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data | Q29615647 | ||
| Quality control for functional magnetic resonance imaging using automated data analysis and Shewhart charting | Q30578281 | ||
| Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water | Q30744027 | ||
| Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. | Q33814201 | ||
| Remission in schizophrenia: proposed criteria and rationale for consensus | Q33985442 | ||
| Chlorpromazine equivalent doses for the newer atypical antipsychotics | Q34208233 | ||
| Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study | Q34415862 | ||
| Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study | Q35861759 | ||
| Alterations in white matter evident before the onset of psychosis. | Q36386344 | ||
| Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment | Q36442033 | ||
| Evidence for white matter abnormalities in schizophrenia | Q36460207 | ||
| Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia | Q37076476 | ||
| Diffusion tensor imaging in schizophrenia: relationship to symptoms | Q37158245 | ||
| Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments | Q37981491 | ||
| Cortical folding defects as markers of poor treatment response in first-episode psychosis | Q39366868 | ||
| In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia | Q40277970 | ||
| Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST). | Q43264112 | ||
| A classification of hand preference by association analysis | Q43417723 | ||
| A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system | Q43754027 | ||
| Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia | Q44671674 | ||
| Pituitary volume and early treatment response in drug-naïve first-episode psychosis patients. | Q45974373 | ||
| White matter defects in first episode psychosis patients: a voxelwise analysis of diffusion tensor imaging | Q46635348 | ||
| Early Prediction of Antipsychotic Response in Schizophrenia | Q47409097 | ||
| P433 | issue | Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | psychosis | Q170082 |
| P304 | page(s) | 172-182 | |
| P577 | publication date | 2013-11-19 | |
| P1433 | published in | Brain | Q897386 |
| P1476 | title | White matter integrity as a predictor of response to treatment in first episode psychosis | |
| P478 | volume | 137 |
| Q90214688 | A Dissociation in Effects of Risperidone Monotherapy on Functional and Anatomical Connectivity Within the Default Mode Network |
| Q90427479 | A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter |
| Q92459002 | A longitudinal neurite and free water imaging study in patients with a schizophrenia spectrum disorder |
| Q99604509 | A potential biomarker for treatment stratification in psychosis: evaluation of an [18F] FDOPA PET imaging approach |
| Q36994859 | Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study |
| Q47861621 | Age and gender interactions in white matter of schizophrenia and obsessive compulsive disorder compared to non-psychiatric controls: commonalities across disorders |
| Q48467219 | Altered integrity of the right arcuate fasciculus as a trait marker of schizophrenia: a sibling study using tractography-based analysis of the whole brain |
| Q35629742 | Assessment of Lifespan Functioning Attainment (ALFA) scale: A quantitative interview for self-reported current and functional decline in schizophrenia |
| Q36838322 | Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment. |
| Q55032220 | Brain vascular heterogeneity: implications for disease pathogenesis and design of in vitro blood-brain barrier models. |
| Q60445377 | Childhood trauma- and cannabis-associated microstructural white matter changes in patients with psychotic disorder: a longitudinal family-based diffusion imaging study |
| Q58596335 | Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia |
| Q39070362 | Connectomic correlates of response to treatment in first-episode psychosis. |
| Q54965265 | Corpus callosum volumes in the 5 years following the first-episode of schizophrenia: Effects of antipsychotics, chronicity and maturation. |
| Q35950801 | Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis |
| Q47170707 | Differential Time Course of Microstructural White Matter in Patients With Psychotic Disorder and Individuals at Risk: A 3-Year Follow-up Study |
| Q87992766 | Diffusion Imaging of White Matter In Schizophrenia: Progress and Future Directions |
| Q33938847 | Distribution of tract deficits in schizophrenia |
| Q33670642 | Does neuroimaging have a role in predicting outcomes in psychosis? |
| Q42384613 | Editorial: Third-Generation Neuroimaging: Translating Research into Clinical Utility |
| Q48413208 | Effective connectivity during episodic memory retrieval in schizophrenia participants before and after antipsychotic medication. |
| Q57820149 | Fractional Anisotropic Changes of Corpus Callosum Associated with Antipsychotic Treatment in First-Episode Antipsychotic Drug-Naive Patients with Schizophrenia |
| Q36609798 | Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade |
| Q37308713 | Globally Efficient Brain Organization and Treatment Response in Psychosis: A Connectomic Study of Gyrification |
| Q46649475 | Heterochronicity of white matter development and aging explains regional patient control differences in schizophrenia |
| Q64999981 | Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia. |
| Q92094312 | If there is not one cure for schizophrenia, there may be many |
| Q47373916 | Investigation of superior longitudinal fasciculus fiber complexity in recent onset psychosis. |
| Q37015339 | Is neuroimaging clinically useful in subjects at high risk for psychosis? |
| Q98286116 | Is treatment-resistant schizophrenia associated with distinct neurobiological callosal connectivity abnormalities? |
| Q92245093 | Micro- and Macrostructural White Matter Integrity in Never-Treated and Currently Unmedicated Patients With Schizophrenia and Effects of Short-Term Antipsychotic Treatment |
| Q30383611 | Molecular substrates of schizophrenia: homeostatic signaling to connectivity |
| Q57473376 | N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial |
| Q33762573 | Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage |
| Q27000120 | Neuroimaging biomarkers to predict treatment response in schizophrenia: the end of 30 years of solitude? |
| Q89314064 | Neuroimaging markers of antipsychotic treatment response in schizophrenia: An overview of magnetic resonance imaging studies |
| Q64253534 | Prediction of early response to overall treatment for schizophrenia: A functional magnetic resonance imaging study |
| Q31137558 | Psychoradiology: The Frontier of Neuroimaging in Psychiatry. |
| Q60062678 | Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE) |
| Q42329943 | Risperidone-induced topological alterations of anatomical brain network in first-episode drug-naive schizophrenia patients: a longitudinal diffusion tensor imaging study |
| Q47834944 | Shared and distinct alterations of white matter tracts in remitted and nonremitted patients with schizophrenia. |
| Q47301729 | State-dependent microstructural white matter changes in drug-naïve patients with first-episode psychosis. |
| Q36348922 | Structural brain changes in schizophrenia at different stages of the illness: A selective review of longitudinal magnetic resonance imaging studies |
| Q64091064 | Subtle white matter alterations in schizophrenia identified with a new measure of fiber density |
| Q36184932 | The Paradoxical Relationship between White Matter, Psychopathology and Cognition in Schizophrenia: A Diffusion Tensor and Proton Spectroscopic Imaging Study |
| Q38232366 | The neurobiology and treatment of first-episode schizophrenia |
| Q34243270 | The stimulus selectivity and connectivity of layer six principal cells reveals cortical microcircuits underlying visual processing. |
| Q30357824 | Tractography Analysis of 5 White Matter Bundles and Their Clinical and Cognitive Correlates in Early-Course Schizophrenia. |
| Q47958113 | White Matter Disruptions in Schizophrenia Are Spatially Widespread and Topologically Converge on Brain Network Hubs. |
| Q27686764 | White matter development in the early stages of psychosis. |
| Q94599929 | White matter integrity, duration of untreated psychosis, and antipsychotic treatment response in medication-naïve first-episode psychosis patients |
| Q35540314 | White matter microstructure in schizophrenia: associations to neurocognition and clinical symptomatology |
| Q40119382 | White-matter connectivity related to paliperidone treatment response in patients with schizophrenia |
Search more.